About GenEp
GenEp is a company based in Charlottesville (United States) founded in 2021.. GenEp has raised $10.4 million across 3 funding rounds from investors including University of Virginia, 3B Future Health Fund and Kids Connect Charitable Fund. GenEp operates in a competitive market with competitors including Marinus Pharma, Arvelle Therapeutics, ORPHELIA Pharma, EpilepsyGTx and Corlieve Therapeutics, among others.
- Headquarter Charlottesville, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.4 M (USD)
in 3 rounds
-
Latest Funding Round
$4 M (USD), Series A
Jul 17, 2024
-
Investors
University of Virginia
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of GenEp
GenEp has successfully raised a total of $10.4M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $4.0M
-
First Round
First Round
(26 Oct 2021)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2024 | Amount | Series A - GenEp | Valuation |
investors |
|
| May, 2023 | Amount | Series A - GenEp | Valuation |
investors |
|
| Oct, 2021 | Amount | Seed - GenEp | Valuation | University of Virginia , 3B Future Health Fund |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GenEp
GenEp has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include University of Virginia, 3B Future Health Fund and Kids Connect Charitable Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage healthcare investments are made by 3B Future Health Fund.
|
Founded Year | Domain | Location | |
|
Angelini Ventures is focused on investing in BioTech and Digital Health.
|
Founded Year | Domain | Location | |
|
Multiple courses and degrees across diversified streams are offered.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GenEp
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GenEp
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genep Comparisons
Competitors of GenEp
GenEp operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Marinus Pharma, Arvelle Therapeutics, ORPHELIA Pharma, EpilepsyGTx and Corlieve Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapeutics to treat seizure disorders
|
|
| domain | founded_year | HQ Location |
Small molecule therapies are developed for partial-onset seizures treatment.
|
|
| domain | founded_year | HQ Location |
Therapies for pediatric neurology, oncology, and hematology are developed.
|
|
| domain | founded_year | HQ Location |
Gene therapies for focal refractory epilepsy are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurological disorders are developed using AAV gene delivery.
|
|
| domain | founded_year | HQ Location |
Develops drugs for rare neurological disorders including sleep, neurobehavioral, and epilepsy conditions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about GenEp
When was GenEp founded?
GenEp was founded in 2021.
Where is GenEp located?
GenEp is headquartered in Charlottesville, United States. It is registered at Charlottesville, Virginia, United States.
Who is the current CEO of GenEp?
Andrew J Krouse is the current CEO of GenEp.
Is GenEp a funded company?
GenEp is a funded company, having raised a total of $10.4M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.45M, raised on Oct 26, 2021.
What does GenEp do?
GenEp was founded in 2021 in Charlottesville, United States, within the biotechnology sector. Therapeutics for epilepsy treatment are developed, with a focus on mutations in sodium and other ion channels. Rare genetic epilepsies and treatment-resistant forms are addressed through these targeted therapies. Operations center on creating solutions for unmet needs in epilepsy care.
Who are the top competitors of GenEp?
GenEp's top competitors include Marinus Pharma, Arvelle Therapeutics and ORPHELIA Pharma.
Who are GenEp's investors?
GenEp has 5 investors. Key investors include University of Virginia, 3B Future Health Fund, Kids Connect Charitable Fund, Angelini Ventures, and PDI Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.